Vaxcyte, Inc. (PCVX) — Capital Expenditures
| Fiscal Year | Capital Expenditures | Change YoY |
|---|---|---|
| 2025 | $13.71M | -38.9% |
| 2024 | $22.43M | +39.6% |
| 2023 | $16.06M | +175.0% |
| 2022 | $5.84M | -10.9% |
| 2021 | $6.55M | +467.5% |
| 2020 | $1.16M | -3.3% |
| 2019 | $1.20M | -32.6% |
| 2018 | $1.77M | — |
| Fiscal Year | Capital Expenditures | Change YoY |
|---|---|---|
| 2025 | $13.71M | -38.9% |
| 2024 | $22.43M | +39.6% |
| 2023 | $16.06M | +175.0% |
| 2022 | $5.84M | -10.9% |
| 2021 | $6.55M | +467.5% |
| 2020 | $1.16M | -3.3% |
| 2019 | $1.20M | -32.6% |
| 2018 | $1.77M | — |